(Q43556342)

24 November 2017

Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio (English)

1 reference

24 November 2017

Gallay BJ

1

1 reference

24 November 2017

Ahmad S

2

1 reference

24 November 2017

Xu L

3

1 reference

24 November 2017

Toivola B

4

1 reference

24 November 2017

Davidson RC

5

1 reference

24 November 2017

1 April 2001

1 reference

American Journal of Kidney Diseases

24 November 2017

1 reference

24 November 2017

37

1 reference

24 November 2017

699-705

1 reference

24 November 2017

4

1 reference

Primary aldosteronism: hypertension with a genetic basis

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980117-7

7 January 2021

High incidence of primary aldosteronism in 199 patients referred with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980117-7

7 January 2021

Potentially high prevalence of primary aldosteronism in a primary-care population

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980117-7

7 January 2021

Primary Aldosteronism: Diagnosis and Differentiation of Subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980117-7

7 January 2021

The changing clinical spectrum of primary aldosteronism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980117-7

7 January 2021

NORMOKALEMIC PRIMARY ALDOSTERONISM. A DETECTABLE CAUSE OF CURABLE "ESSENTIAL" HYPERTENSION

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980117-7

7 January 2021

Diagnosis and treatment of primary hyperaldosteronism.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980117-7

7 January 2021

A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980117-7

7 January 2021

Is aldosterone/renin ratio useful to screen a hypertensive population for primary aldosteronism?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980117-7

7 January 2021

Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980117-7

7 January 2021

The diagnosis of primary aldosteronism and separation of two major subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980117-7

7 January 2021

Use of computed tomography in diagnosing the cause of primary aldosteronism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980117-7

7 January 2021

Magnetic resonance imaging (2)

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980117-7

7 January 2021

Adrenal cortical and medullary imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980117-7

7 January 2021

Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980117-7

7 January 2021

Therapeutic effect of calcium channel blockade in primary aldosteronism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2980117-7

7 January 2021

10.1016/S0272-6386(01)80117-7

Identifiers

DOI

1 reference

24 November 2017

1 reference